Fused polycyclic heteroaromatic compound, organic thin film including compound and electronic device including organic thin film

US9537102B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9537102-B2
Application numberUS-201313910246-A
CountryUS
Kind codeB2
Filing dateJun 5, 2013
Priority dateJun 5, 2012
Publication dateJan 3, 2017
Grant dateJan 3, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A low-molecular-weight fused polycyclic heteroaromatic compound may have a compact planar structure in which seven or more rings are fused together, and thereby exhibits high charge mobility, and furthermore, enables the use of a deposition process or a room-temperature solution process when applied to devices, therefore realizing improved processibility. An organic thin film and electronic device may include the fused polycyclic heteroaromatic compound.

First claim

Opening claim text (preview).

What is claimed is: 1. A fused polycyclic heteroaromatic compound comprising a structural unit represented by the following Chemical Formula 1: wherein, in the above Chemical Formula 1, Ar is one of a substituted or unsubstituted benzene, a substituted or unsubstituted naphthalene, and a substituted or unsubstituted anthracene, each of X 1 to X 4 are independently one of O, S, Se, Te, N—R a , and CR b , wherein each of R a and R b are independently one of hydrogen, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 1 to C 30 alkoxy group, —OR 11 , wherein R 11 is a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 4 to C 30 cycloalkyl group, —OR 12 , wherein R 12 is a substituted or unsubstituted C 4 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group, —C(═O)R 13 , wherein R 13 is a substituted or unsubstituted C 1 to C 30 alkyl group, —S(═O) 2 R 14 , wherein R 14 is a substituted or unsubstituted C 1 to C 30 alkyl group, and —NHC(═O)OR 15 , wherein R 15 is a substituted or unsubstituted C 1 to C 30 alkyl group, at least one of X 1 and X 2 is selected from O, S, Se, and Te, at least one of X 3 and X 4 is selected from O, S, Se, and Te, each of X 5 and X 6 are independently one of O, S, Se, Te, and CR b R c wherein each of R b to R c are independently one of hydrogen, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 1 to C 30 alkoxy group, —OR 11 , wherein R 11 is a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 4 to C 30 cycloalkyl group, —OR 12 , wherein R 12 is a substituted or unsubstituted C 4 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group, —C(═O)R 13 , wherein R 13 is a substituted or unsubstituted C 1 to C 30 alkyl group, —S(═O) 2 R 14 , wherein R 14 is a substituted or unsubstituted C 1 to C 30 alkyl group, and —NHC(═O)OR 15 , wherein R 15 is a substituted or unsubstituted C 1 to C 30 alkyl group, and each of R 1 to R 6 are independently one of hydrogen, —F, —Cl, —Br, —I, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkenyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkynyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 2 to C 30 heteroarylalkyl group, a substituted or unsubstituted C 2 to C 30 alkylheteroaryl group, a substituted or unsubstituted C 5 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, and a substituted or unsubstituted C 2 to C 30 heteroaryl group. 2. The fused polycyclic heteroaromatic compound of claim 1 , wherein the fused polycyclic heteroaromatic compound is represented by the following Chemical Formula 1A: wherein, in the above Chemical Formula 1A, each of X 1 to X 4 are independently one of O, S, Se, Te, N—R a , and CR b , wherein each of R a and R b are independently one of hydrogen, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 1 to C 30 alkoxy group, —OR 11 , wherein R 11 is a substituted or unsubstituted C 6 to C 30 aryl group), a substituted or unsubstituted C 4 to C 30 cycloalkyl group, —OR 12 , wherein R 12 is a substituted or unsubstituted C 4 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group, —C(═O)R 13 , wherein R 13 is a substituted or unsubstituted C 1 to C 30 alkyl group, —S(═O) 2 R 14 , wherein R 14 is a substituted or unsubstituted C 1 to C 30 alkyl group, and —NHC(═O)OR 15 , wherein R 15 is a substituted or unsubstituted C 1 to C 30 alkyl group, at least one of X 1 and X 2 is selected from O, S, Se, and Te, at least one of X 3 and X 4 is selected from O, S, Se, and Te, each of X 5 and X 6 are independently one of O, S, Se, Te, and CR b R c wherein each of R b to R c are independently one of hydrogen, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 1 to C 30 alkoxy group, —OR 11 , wherein R 11 is a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 4 to C 30 cycloalkyl group, —OR 12 , wherein R 12 is a substituted or unsubstituted C 4 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group, —C(═O)R 13 , wherein R 13 is a substituted or unsubstituted C 1 to C 30 alkyl group, —S(═O) 2 R 14 , wherein R 14 is a substituted or unsubstituted C 1 to C 30 alkyl group, and —NHC(═O)OR 15 , wherein R 15 is a substituted or unsubstituted C 1 to C 30 alkyl group, each of R 1 to R 6 are independently one of hydrogen, —F, —Cl, —Br, —I, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkenyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkynyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 2 to C 30 heteroarylalkyl group, a substituted or unsubstituted C 2 to C 30 alkylheteroaryl group, a substituted or unsubstituted C 5 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, and a substituted or unsubstituted C 2 to C 30 heteroaryl group, R 100 is hydrogen, —F, —Cl, —Br, —I, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkenyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkynyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 2 to C 30 heteroarylalkyl group, a substituted or unsubstituted C 2 to C 30 alkylheteroaryl group, a substituted or unsubstituted C 5 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, or a substituted or unsubstituted C 2 to C 30 heteroaryl group, and x is an integer of 1 or 2. 3. The fused polycyclic heteroaromatic compound of claim 2 , wherein, in Chemical Formula 1A, each of R 1 to R 6 are independently one of a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkenyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkynyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 2 to C 30 heteroarylalkyl group, a substituted or unsubstituted C 2 to C 30 alkylheteroaryl group, a substituted or unsubstituted C 5 to C 30 cycloa

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9537102B2 cover?
A low-molecular-weight fused polycyclic heteroaromatic compound may have a compact planar structure in which seven or more rings are fused together, and thereby exhibits high charge mobility, and furthermore, enables the use of a deposition process or a room-temperature solution process when applied to devices, therefore realizing improved processibility. An organic thin film and electronic dev…
Who is the assignee on this patent?
Samsung Electronics Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07D495/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).